Dosidal · Switzerland

Agamree, Suspension zum Einnehmen

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:69650 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 69650
atc: H02AB18
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2026-01-14
term: zugelassen
valid_until: 2031-01-13
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: H02AB18
authorisation_number: 69650
form: SUOR
holder: Santhera Pharmaceuticals (Schweiz)
holder_partner_nr: 1002326
it_number: 01.99.0.
name: Agamree, Suspension zum Einnehmen
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
rU_kw-FANiDzsQCUKCaJ9bcRXFy3hpQyWDk3E-kjN3Dbv4eD7FPTnfYEEEo6n1ntpAt5Ofl_6U700cPzVcFg0A
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:69650 · Related records in other markets · Dosidal